Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,248,479
Closed -$41.4M 33
2021
Q4
$41.4M Buy
1,248,479
+50,466
+4% +$1.6M 6.42% 2
2021
Q3
$35M Buy
1,198,013
+41,085
+4% +$1.23M 5.95% 4
2021
Q2
$35.3M Buy
1,156,928
+62,906
+6% +$1.99M 5.83% 3
2021
Q1
$32.4M Buy
1,094,022
+161,631
+17% +$4.63M 5.69% 1
2020
Q4
$26.6M Buy
932,391
+167,727
+22% +$4.57M 5.7% 2
2020
Q3
$17M Buy
764,664
+16,450
+2% +$381K 4.2% 8
2020
Q2
$16.9M Buy
+748,214
New +$15.3M 4.48% 5

Other funds holding AXTA

M.D. Sass LLC's AXTA Position: Q1 2022 in Review

M.D. Sass LLC sold out of Axalta (AXTA) in Q1 2022, closing a stake of 1,248,479 shares — an estimated $41.4M sold.

M.D. Sass LLC first reported a position in AXTA in Q2 2020 and held it in 7 quarters. The position peaked at $41.4M in Q4 2021. 303 funds tracked by Wall St. Rank hold AXTA as of Q1 2022.

  • M.D. Sass LLC reported no remaining Axalta position as of Q1 2022 after selling out during the quarter.
  • M.D. Sass LLC sold 1,248,479 Axalta shares in Q1 2022, an estimated $41.4M.
  • M.D. Sass LLC first reported a position in Axalta in Q2 2020 and held it in 7 quarters.
  • M.D. Sass LLC's Axalta position peaked at $41.4M in Q4 2021.
  • 303 funds tracked by Wall St. Rank held Axalta as of Q1 2022.

Based on M.D. Sass LLC's 13F filing for Q1 2022, filed 12 May 2022.